NASDAQ
74.23USD
+0.91 (+1.24%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
14.5B
P/E
—
EPS
—
Beta
0.84
52W range
58.89-89.83
Day range
72.65–74.58
Open
73.03
Prev close
73.32
Volume
1.5M
Avg volume
2.9M
Dividend
0.01
IPO
1983-01-21
https://www.zacks.com/stock/news/2955109/reasons-to-retain-cooper-companies-stock-in-your-portfolio-for-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rank_focused-2955109 · 7/16/2026+0.20
https://www.zacks.com/stock/news/2945711/is-coo-stock-attractive-as-myday-gains-meet-asia-pacific-pressure?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2945711 · 6/30/2026+0.40
https://www.zacks.com/stock/news/2945710/how-coo-is-balancing-premium-lens-growth-against-asia-pacific-risks?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2945710 · 6/30/2026+0.40
https://www.zacks.com/stock/news/2932730/the-cooper-companies-coo-beats-q2-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2932730 · 6/4/2026+0.60
https://www.zacks.com/stock/news/2890701/reasons-to-add-cooper-companies-stock-to-your-portfolio-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rank_focused-2890701 · 3/27/2026+0.40
https://www.defenseworld.net/2026/03/07/cooper-companies-q1-earnings-call-highlights.html · 3/7/2026+0.80
https://www.zacks.com/stock/news/2879705/the-cooper-companies-coo-q1-earnings-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2879705 · 3/5/2026+0.40
https://www.zacks.com/stock/news/2828249/reasons-to-add-cooper-companies-stock-to-your-portfolio-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rank_focused-2828249 · 2/3/2026+0.40
https://www.zacks.com/stock/news/2828192/will-the-cooper-companies-coo-beat-estimates-again-in-its-next-earnings-report?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_7-2828192 · 2/3/2026+0.80
https://www.defenseworld.net/2026/01/19/the-cooper-companies-inc-nasdaqcoo-given-average-rating-of-moderate-buy-by-brokerages.html · 1/19/2026+0.40
https://www.defenseworld.net/2025/12/12/frontier-capital-management-co-llc-raises-stake-in-the-cooper-companies-inc-coo.html · 12/12/2025+0.40
https://www.investopedia.com/s-and-p-500-gains-and-losses-today-ulta-beauty-pops-netflix-warner-bros-deal-shakes-up-streaming-stocks-ulta-nflx-wbd-11863191 · 12/5/2025+0.80
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
